NCT03273153 · Interventional trial
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
Overall registry status Terminated
Phase 3
Conditions Advanced BRAFV600 Wild-type Melanoma
Delaware Valley sites
- Thomas Jefferson University Hospital;Medical Oncology · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory